Skip to main content
Fig. 7 | BMC Molecular and Cell Biology

Fig. 7

From: An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat model

Fig. 7

Neovascularization leakage areas analysis (IOD/Area, comparison in 3 groups). a Neovascularization leakage areas analysis at 1 h. b Neovascularization leakage areas analysis at 1d. c Neovascularization leakage areas analysis at 3d. d Neovascularization leakage areas analysis at 5d. *P < 0.05, **P < 0.01, ***P < 0.0001 as compared with OIR + endostatin-lentivirus; ##P < 0.01, ###P < 0.001 as compared with OIR + EPCs. OIR + ES-LV: OIR rats with endostatin-lentivirus intravitreal injection; OIR + EPCs: OIR rats with EPCs intravitreal injection; OIR + ES-LV-EPCs: OIR rats with endostatin-lentivirus-EPCs intravitreal injection

Back to article page
\